Sharecare Inc has a consensus price target of $1.52, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, BTIG, and BTIG on April 15, 2024, April 1, 2024, and June 2, 2023. With an average price target of $2 between Morgan Stanley, BTIG, and BTIG, there's an implied 166.74% upside for Sharecare Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/15/2024 | SHCR | Buy Now | Sharecare | $0.75 | 33.37% | Morgan Stanley | Craig Hettenbach | $1.5 → $1 | Maintains | Equal-Weight | Get Alert |
04/01/2024 | SHCR | Buy Now | Sharecare | $0.75 | — | BTIG | David Larsen | — | Downgrade | Buy → Neutral | Get Alert |
06/02/2023 | SHCR | Buy Now | Sharecare | $0.75 | 566.84% | BTIG | David Larsen | → $5 | Reiterates | → Buy | Get Alert |
03/30/2023 | SHCR | Buy Now | Sharecare | $0.75 | 166.74% | Morgan Stanley | Craig Hettenbach | $2.5 → $2 | Maintains | Equal-Weight | Get Alert |
11/11/2022 | SHCR | Buy Now | Sharecare | $0.75 | 300.11% | Canaccord Genuity | Richard Close | $4 → $3 | Maintains | Buy | Get Alert |
10/05/2022 | SHCR | Buy Now | Sharecare | $0.75 | 566.84% | BTIG | David Larsen | $8 → $5 | Maintains | Buy | Get Alert |
09/21/2022 | SHCR | Buy Now | Sharecare | $0.75 | 180.07% | Goldman Sachs | Cindy Motz | $1.5 → $2.1 | Maintains | Neutral | Get Alert |
07/20/2022 | SHCR | Buy Now | Sharecare | $0.75 | 233.42% | Morgan Stanley | Craig Hettenbach | → $2.5 | Initiates | → Equal-Weight | Get Alert |
04/01/2022 | SHCR | Buy Now | Sharecare | $0.75 | 1233.69% | BTIG | David Larsen | $15 → $10 | Maintains | Buy | Get Alert |
04/01/2022 | SHCR | Buy Now | Sharecare | $0.75 | 433.48% | Goldman Sachs | Cindy Motz | $4.5 → $4 | Maintains | Neutral | Get Alert |
02/11/2022 | SHCR | Buy Now | Sharecare | $0.75 | — | Goldman Sachs | Cindy Motz | — | Initiates | → Neutral | Get Alert |
08/04/2021 | SHCR | Buy Now | Sharecare | $0.75 | 1367.06% | Canaccord Genuity | Richard Close | — | Initiates | → Buy | Get Alert |
07/28/2021 | SHCR | Buy Now | Sharecare | $0.75 | 1900.53% | BTIG | David Larsen | — | Initiates | → Buy | Get Alert |
The latest price target for Sharecare (NASDAQ: SHCR) was reported by Morgan Stanley on April 15, 2024. The analyst firm set a price target for $1.00 expecting SHCR to rise to within 12 months (a possible 33.37% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Sharecare (NASDAQ: SHCR) was provided by Morgan Stanley, and Sharecare maintained their equal-weight rating.
There is no last upgrade for Sharecare.
The last downgrade for Sharecare Inc happened on April 1, 2024 when BTIG changed their price target from N/A to N/A for Sharecare Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sharecare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sharecare was filed on April 15, 2024 so you should expect the next rating to be made available sometime around April 15, 2025.
While ratings are subjective and will change, the latest Sharecare (SHCR) rating was a maintained with a price target of $1.50 to $1.00. The current price Sharecare (SHCR) is trading at is $0.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.